Phenex Pharmaceuticals AG was founded in 2002. It is a privately owned drug discovery & development company based in the Biotech Cluster Rhine-Neckar in Heidelberg. Our company focuses its small-molecule drug discovery expertise in Liver diseases and in Cancer. Our aim is to translate novel scientific findings into best-in-class therapies that change current therapeutic regimens. The most advanced novel drug, Cilofexor, is currently in phase 2 clinical development by Gilead Sciences, to whom we sold this program in 2014. For more information about Phenex Pharmaceuticals AG, please visit our website at: www.phenex-pharma.com and follow us on Twitter at: @PhenexPharma
